This cardiometabolic KOL perception study provides valuable insights into precision medicine, GLP-1 therapies, digital health, and multidisciplinary care. Explore how healthcare leaders believe innovation, AI, and personalized treatment approaches will transform cardiometabolic disease management over the coming years.




